BAY2253651 / Bayer - LARVOL DELTA

BAY 2253651 for the treatment of obstructive sleep apnea: a multi-center, double-blind, randomized controlled trial (SANDMAN). (PubMed, Eur Respir J) - No abstract available

Clinical • Journal • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder

SANDMAN: Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor (clinicaltrials.gov) - P2; N=34; Completed; Sponsor: Bayer; Active, not recruiting ➔ Completed

Clinical • Trial completion